Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
23.48
+0.21 (0.90%)
At close: Oct 6, 2025, 4:00 PM EDT
23.48
0.00 (0.00%)
After-hours: Oct 6, 2025, 4:10 PM EDT
Phreesia Market Cap
Phreesia has a market cap or net worth of $1.41 billion as of October 6, 2025. Its market cap has increased by 1.59% in one year.
Market Cap
1.41B
Enterprise Value
1.32B
1-Year Change
1.59%
Ranking
Category
Stock Price
$23.48
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.45M to $1.41B, an increase of 59.96%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 1.39B | -4.66% |
| Dec 31, 2024 | 1.46B | 13.55% |
| Dec 29, 2023 | 1.29B | -24.54% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | 2.40B | 150.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |